Using light therapy to help young adults with OCD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of light therapy in reducing symptoms of obsessive-compulsive disorder (OCD) in young adults who have late bedtimes. Participants will wear light therapy glasses for one hour each morning over a five-week period and track their sleep patterns using a wearable monitor and electronic diary. The study will also assess the impact of different doses of light therapy on symptom reduction and circadian rhythm adjustments. Self-report measures of OCD symptoms will be collected multiple times throughout the study to gauge changes in severity.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Primary DSM-5 OCD diagnosis
2. Bedtime 0100 or later
3. Age 18-35
4. English speaking

Exclusion Criteria:

1. Subjects must not be currently participating in another research study that would influence their participation in our study.
2. Diagnostic status
3. Treatment status
4. Night shift work or travel more than 1 time zone outside of Central Standard Time (CST) in the past month
5. Pregnancy status
6. Medication status
7. Regular nicotine or marijuana use

Where it's running

• Washington University
  St Louis, Missouri, United States Recruiting

Study contacts

• Principal investigator: Rebecca Cox, PhD — Washington University School of Medicine
• Study coordinator: Rebecca Cox, BA
• Email: scraplab@wustl.edu
• Phone: 314-935-8111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD

  This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.

  Recruiting Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07704632

• Emotion-Focused ACT for OCD in Group Therapy

  In adults with OCD, researchers will test whether Emotion-Focused Acceptance and Commitment Therapy (ACT) delivered in a group setting helps reduce OCD symptoms compared with a supportive group.

  Recruiting Goztepe Prof Dr Suleyman Yalcın City Hospital · Istanbul, Istanbul · NCT07622654

• Analyzing mental health treatment data from Greenbrook

  This study looks at past treatment data from Greenbrook to see how well different mental health treatments, like NeuroStar TMS and Esketamine, work for people with depression, OCD, and anxiety.

  Recruiting Neuronetics · Malvern, Pennsylvania · NCT06997549

• Optimizing youth mental health trajectories

  This study is trying to understand how mental health changes in young people aged 9 to 25 over five years to see if we can help prevent problems like depression and ADHD.

  Recruiting Douglas Mental Health University Institute · Montreal, Quebec · NCT06978452

• Team-delivered exposure-based CBT for children and teens with anxiety and OCD

  This test tries three ways of delivering team-based exposure-focused CBT—in-person, by telehealth, or a flexible mix—to see which works best for kids and teens (ages 5–18) with anxiety or OCD.

  Recruiting Bradley Hospital · East Providence, Rhode Island · NCT06934525

• Psilocybin treatment for individuals with various psychiatric symptoms

  This study is testing if a single dose of psilocybin can help people with different mental health issues like depression, anxiety, and PTSD feel better and improve their daily functioning.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT06442423

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.